Roche Q3 Results - Q3 Top Pharma Company Earnings Reports

View Roche's Q3 Earnings Report

Highlights:

  • Group sales up 3.1 billion to 36.4 billion Swiss francs in first nine months, an increase of 11% in local currencies (9% in Swiss francs); both divisions grow significantly faster than their respective markets
  • Genentech integration progressing successfully
  • New Group leadership appointed

Check out Roche's current earnings estimates from CNN Money

Roche's Website: http://www.roche.com/

Roche Q3 Results - Q3 Top Pharma Company Earnings Reports
Read more on

Suggested Articles

With a seven-figure opioid settlement in the works and its generics unit facing bankruptcy, Mallinckrodt will lean on Acthar Gel for future growth.

After a draft report last November, ICER's final findings on Allergan and Biohaven migraine medicines are more favorable.

As part of a multi-year asset offload, AstraZeneca has divested most of its global rights to constipation med Movantik to RedHill Biopharma.